Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Alzheimer's Disease

Free Subscription 31.08.2026 3 Alzheimer Dis Assoc Disord 15 Alzheimers Dement 1 Am J Geriatr Psychiatry 1 BMC Geriatr 7 Curr Alzheimer Res 1 Geriatrics (Basel) 3 J Alzheimers Dis 1 J Am Geriatr Soc 1 J Biol Chem 1 J Neurochem 2 J Neurol Neurosurg Psychiatry 1 J Neurosci 1 Nature 1 Neurobiol Aging 1 Neurol Genet 2 Neurology 2 Neuroscience 2 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Alzheimer Dis Assoc Disord

1. ALMEIDA MM, Fernandes CS, Campos Ferreira M
   Co-Design and Development of Digital Health Solution for Informal Alzheimer's Caregivers.
   Alzheimer Dis Assoc Disord. 2026 Aug 27. doi: 10.1097/WAD.0000000000000740.
   PubMed         Abstract available
   
   
2. XU D, Jiang L, Yang Q, Marzo RR, et al
   Projected Global and SDI-Region Care Costs for Alzheimer Disease and Associated Dementias, 2023 to 2050: A Stratified Analysis Based on Global Burden of Disease (GBD) Data.
   Alzheimer Dis Assoc Disord. 2026 Aug 27. doi: 10.1097/WAD.0000000000000748.
   PubMed         Abstract available
   
   
3. PEREIRA DA SILVA AM, Santos do Nascimento MDV, Menegucci G, Caruso Novaes Tudella G, et al
   Pioglitazone and Cognitive Outcomes in Mild Cognitive Impairment and Alzheimer Disease: A Systematic Review and Meta-Analysis of Randomized Trials.
   Alzheimer Dis Assoc Disord. 2026 Aug 25. doi: 10.1097/WAD.0000000000000744.
   PubMed         Abstract available
   
   

   
   Alzheimers Dement

4. ROMANO CD, Bratlee-Whitaker E, Hartry A, Taylor J, et al
   Priorities of people living with Alzheimer's and care partners: What Matters Most?
   Alzheimers Dement. 2026;22:e71554.
   PubMed         Abstract available
   
   
5. HILL C, Morgan H, Michopoulou S, Niranjan M, et al
   Dynamic imaging markers of incident microhemorrhages and superficial siderosis in the A4 study: A longitudinal person-interval analysis.
   Alzheimers Dement. 2026;22:e71792.
   PubMed         Abstract available
   
   
6. ZHAO K, Xie H, Jacobs T, Gaggi NL, et al
   Elucidating the neuropathological and molecular heterogeneity of amyloid beta and tau in Alzheimer's disease through machine learning and transcriptomic integration.
   Alzheimers Dement. 2026;22:e71757.
   PubMed         Abstract available
   
   
7. HENDRIX S, Mallinckrodt C, Abschneider RM, Atri A, et al
   Estimating treatment effects in clinical studies of Alzheimer's disease: What are estimands and why do we need them?
   Alzheimers Dement. 2026;22:e71676.
   PubMed         Abstract available
   
   
8. KANG H, Jang H, Ahn J, Na DL, et al
   APOE-guided lecanemab dosing dissociates ARIA-E from ARIA-H: The K-ROAD study.
   Alzheimers Dement. 2026;22:e71765.
   PubMed         Abstract available
   
   
9. MORATO X, Hinojosa-Calleja A, Jofresa S, Calm B, et al
   When treatment becomes risk: polypharmacy and inappropriate prescribing in cognitive impairment in 2379 consecutive patients from a memory clinic.
   Alzheimers Dement. 2026;22:e71708.
   PubMed         Abstract available
   
   
10. KWAPONG WR, Wen C, Wang Y, Hu S, et al
    Retinal microvascular alterations and glymphatic dysfunction mediate the association between APOE epsilon4 and cognitive decline in Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71785.
    PubMed         Abstract available
    
    
11. CHAACHOU-CHARRADI A, Burgueno-Garcia I, Camacho-Soriano J, Moline-Marimon T, et al
    Factors associated with intracerebral hemorrhage in confirmed cerebral amyloid angiopathy.
    Alzheimers Dement. 2026;22:e71786.
    PubMed         Abstract available
    
    
12. COCKELL S, Harris SM, Morgan RK, Patti GJ, et al
    Identification of chemicals targeting dementia genes and pathways in the Comparative Toxicogenomics Database.
    Alzheimers Dement. 2026;22:e71775.
    PubMed         Abstract available
    
    
13. DADSENA R, Costa AS, David S, Haberl L, et al
    Longitudinal effects of physical activity on sleep in association with hippocampal-amygdala subfield structure and functional connectivity in Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71651.
    PubMed         Abstract available
    
    
14. NORDBECK AJ, Marta-Ariza M, Ek Olofsson H, Kanshin E, et al
    Disruption of hippocampal upstream regulators of mTOR and insulin pathways in Down syndrome with Alzheimer's disease neuropathology: Preliminary observations.
    Alzheimers Dement. 2026;22:e71776.
    PubMed         Abstract available
    
    
15. QIAN X, Wang Z, Cui P, Chen S, et al
    Multi-omics identification of haptoglobin as a novel target for increased Alzheimer's disease risk associated with obesity through inhibiting the phagocytosis of Abeta by disease-associated microglia.
    Alzheimers Dement. 2026;22:e71759.
    PubMed         Abstract available
    
    
16. KUMAR A, Sharma M, Su Y, Singh S, et al
    Dissecting Alzheimer's proteomic landscape through NULISA profiling of brain cell-specific extracellular vesicles.
    Alzheimers Dement. 2026;22:e71717.
    PubMed         Abstract available
    
    
17. LEP M, Plesingrova K, Sedmik J, Cesnarikova S, et al
    SORL1 variant links endosomal amyloid precursor protein mis-sorting to axonal transport defects and neuronal dysfunction.
    Alzheimers Dement. 2026;22:e71782.
    PubMed         Abstract available
    
    
18. TU T, Zhang QL, Sun ZP, Kang C, et al
    Aberrant aSMA expression reveals broad mossy fiber reorganization integrating with tangle and plaque formation and mitoenergetic alteration in the human hippocampus.
    Alzheimers Dement. 2026;22:e71778.
    PubMed         Abstract available
    
    

    
    Am J Geriatr Psychiatry

19. SHAW JS, Bray MJC, Harrington CK, Rosenberg PB, et al
    Relationship Between SSRI Exposure During Later Life and Clinical and Neuropathological Correlates of Dementia.
    Am J Geriatr Psychiatry. 2026;34:70-83.
    PubMed         Abstract available
    
    

    
    BMC Geriatr

20. SAYED MA, Said A, Meselhy M
    Nutritional modulation of neuroinflammation in Alzheimer's disease and mild cognitive impairment: a systematic review of clinical and preclinical evidence.
    BMC Geriatr. 2026;26:1100.
    PubMed         Abstract available
    
    

    
    Curr Alzheimer Res

21. DU Y, Li J, Han F, Li J, et al
    Safety Comparison of Acetylcholinesterase Inhibitors Using FAERS Spontaneous-Reporting Data: Drug-Specific Reporting Signals and Time-to-Onset Dynamics.
    Curr Alzheimer Res. 2026 Aug 4. doi: 10.2174/0115672050497124260720115932.
    PubMed         Abstract available
    
    
22. MARTINEZ LD, Ortiz Rojas HJ, Loaiza JHI, Terranova DA, et al
    Descriptive Analysis of Genetic Variants in Individuals Without a Clinical Diagnosis of Alzheimer's Disease in a Population from Southwestern Colombia.
    Curr Alzheimer Res. 2026 Aug 3. doi: 10.2174/0115672050477248260724105245.
    PubMed         Abstract available
    
    
23. MOTAMEDI S, Karimi I
    The Black Hole of the Brain: A Novel Energy-Based Therapeutic Perspective for Alzheimer's Disease.
    Curr Alzheimer Res. 2026 Aug 3. doi: 10.2174/0115672050438652260723053125.
    PubMed         Abstract available
    
    
24. TONG Y, Hu G, Liu L, Zhang Y, et al
    Dynamic Entropic Mapping of Alzheimer's Neuropathology: Eyes-Open and Eyes-Closed EEG Biomarkers through Wavelet Entropy Analysis.
    Curr Alzheimer Res. 2026 Aug 10. doi: 10.2174/0115672050450560260119050625.
    PubMed         Abstract available
    
    
25. GUNESLI A, Hussein F
    Subclinical Atherosclerosis Markers in Alzheimer's and Vascular Dementia: A Cross-Sectional Comparison with Healthy Controls.
    Curr Alzheimer Res. 2026 Aug 10. doi: 10.2174/0115672050495193260728050343.
    PubMed         Abstract available
    
    
26. GI Y, Lim H, Jung AH, Lee J, et al
    Regional Fractal Dimension as a Complementary Morphometric Marker in Alzheimer's Disease.
    Curr Alzheimer Res. 2026 Aug 11. doi: 10.2174/0115672050509238260717071733.
    PubMed         Abstract available
    
    
27. SONJI G, Sonji N, El Katerji A
    Orexin Signaling, Glymphatic Clearance, and Preclinical Alzheimer's Disease: A Scoping Review and Hypothesis-Generating Conceptual Framework.
    Curr Alzheimer Res. 2026 Aug 6. doi: 10.2174/0115672050487100260727051112.
    PubMed         Abstract available
    
    

    
    Geriatrics (Basel)

28. MUNOZ-PADROS J, Foguet-Boreu Q, Puigoriol-Juvanteny E, Garolera M, et al
    Premorbid Personality in Alzheimer's Disease and Caregiver Well-Being: The Role of Extraversion.
    Geriatrics (Basel). 2026;11:108.
    PubMed         Abstract available
    
    

    
    J Alzheimers Dis

29. ALSHARAYRI S, Knox S, Cutty M, Mollalo A, et al
    Dual eligibility and neuropsychiatric symptoms and treatment disparities among Medicare Part D beneficiaries with Alzheimer's disease and related dementias.
    J Alzheimers Dis. 2026 Aug 21:13872877261478140. doi: 10.1177/13872877261478140.
    PubMed         Abstract available
    
    
30. SAKURAI K, Kaneda D, Uchida Y, Shibata H, et al
    Network-based statistical mapping of structural covariance alterations in pathologically confirmed argyrophilic grain disease and Alzheimer's disease: An exploratory pilot study.
    J Alzheimers Dis. 2026 Aug 28:13872877261480673. doi: 10.1177/13872877261480673.
    PubMed         Abstract available
    
    
31. DEJGAARD MS, Eide PK, Tangen GG, Skovlund E, et al
    Cognitive profiles in idiopathic normal pressure hydrocephalus and Alzheimer's disease.
    J Alzheimers Dis. 2026 Aug 28:13872877261478264. doi: 10.1177/13872877261478264.
    PubMed         Abstract available
    
    

    
    J Am Geriatr Soc

32. ZHU Y, Wisch JK, Jiao Z, Brown DC, et al
    Driving Navigation in Older Adults Across the Alzheimer's Disease Continuum.
    J Am Geriatr Soc. 2026 Aug 26. doi: 10.1111/jgs.70665.
    PubMed         Abstract available
    
    

    
    J Biol Chem

33. MARIA DE CAMPOS R, Carraro MF, Brandao Bitencourt AL, Jerisha JJ, et al
    Use of high-affinity scFv antibody NUsc1 for isolation and sensitive detection of Alzheimer's-associated amyloid beta oligomers.
    J Biol Chem. 2026 Aug 26:113499. doi: 10.1016/j.jbc.2026.113499.
    PubMed         Abstract available
    
    

    
    J Neurochem

34. LIM D, Tapella L
    From Proteinopathy to Immunopathy in Alzheimer's Disease-A Role for Astrocytic Calcineurin?
    J Neurochem. 2026;170:e70543.
    PubMed        
    
    

    
    J Neurol Neurosurg Psychiatry

35. BELDER CRS, Heslegrave AJ, Swann O, Abel E, et al
    Presymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timing.
    J Neurol Neurosurg Psychiatry. 2026 Aug 24:jnnp-2026-339037.
    PubMed         Abstract available
    
    
36. LAFFITA-MESA JM
    Molecular timeline of preclinical Alzheimer's disease: why Autosomal Dominant Alzheimer's Disease (ADAD) matters.
    J Neurol Neurosurg Psychiatry. 2026 Aug 24:jnnp-2026-339569.
    PubMed        
    
    

    
    J Neurosci

37. MARKOVA TZ, Heston MB, Berry AS
    Tracking the Continuous Time Dynamics of Tau and Depressive Symptoms Across the Alzheimer's Disease Continuum.
    J Neurosci. 2026 Aug 24:e2309252026. doi: 10.1523/JNEUROSCI.2309-25.2026.
    PubMed         Abstract available
    
    

    
    Nature

38. LEE SY, Park E, Lee HE, Kim S, et al
    Aberrant excitatory neuronal ERBB4 promotes Alzheimer's disease pathology.
    Nature. 2026 Aug 26. doi: 10.1038/s41586-026-10964.
    PubMed         Abstract available
    
    

    
    Neurobiol Aging

39. CHO JH, Passera B, Bertazzoli G, Ozdemir RA, et al
    Input-output curves demonstrate motor cortex hyperexcitability associated with cognitive impairment in Alzheimer's disease.
    Neurobiol Aging. 2026;168:147-158.
    PubMed         Abstract available
    
    

    
    Neurol Genet

40. JONES L, Cerquera-Cleves C, Schuh AFS, Makarious M, et al
    Population Attributable Risk in Alzheimer and Parkinson Diseases.
    Neurol Genet. 2026;12:e200415.
    PubMed         Abstract available
    
    

    
    Neurology

41. PARANHOS T, Katsumi Y, Brickhouse MJ, Eloyan A, et al
    EOAD-Signature Atrophy Predicts Dementia in Early-Onset MCI due to Alzheimer Disease: An MRI-Based Prognostic Biomarker.
    Neurology. 2026;107:e218519.
    PubMed         Abstract available
    
    
42. GONZALEZ-GOMEZ R, Tagliazuchi E, Campo CG, Medel V, et al
    Lesion-Level Subtypes of White Matter Hyperintensity Evolution Beyond Spatial Location.
    Neurology. 2026;107:e218472.
    PubMed         Abstract available
    
    

    
    Neuroscience

43. YU H, Lin Z, Hu Z
    Manifold representation learning for Alzheimer's disease detection with EEG-based functional brain connectivity.
    Neuroscience. 2026;615:120-133.
    PubMed         Abstract available
    
    
44. ZHANG L, Wang S, Gui Y, Li D, et al
    Corrigendum to "TLR2 regulation of NF-kappaB and NLRP3-driven pyroptosis in Alzheimer's disease" [Neuroscience 598 (2026) 85-99].
    Neuroscience. 2026;614:355.
    PubMed        
    
    

    
    PLoS One

45. NASIR AB, Kilani Y, Aldiabat M, Abdelghany O, et al
    Antidiabetic medications and risk of cognitive disorders in type 2 diabetes: A retrospective cohort study.
    PLoS One. 2026;21:e0356138.
    PubMed         Abstract available
    
    
46. 
    Expression of Concern: Constipation in Tg2576 mice model for Alzheimer's disease associated with dysregulation of mechanism involving the mAChR signaling pathway and ER stress response.
    PLoS One. 2026;21:e0356955.
    PubMed        
    
    

    
    Proc Natl Acad Sci U S A

47. RUFF DA, Sheets DEG, Srinath R, Diniz GB, et al
    Loss of neuronal population organization links pathology to behavior in a model of Alzheimer's disease.
    Proc Natl Acad Sci U S A. 2026;123:e2614164123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum